Filing Flows › Idexx Laboratories (IDXX) › Q2 2026 › vs Q1 2026
Idexx Laboratories (IDXX) Q2 2026 vs Q1 2026 (quarter over quarter)
Idexx Laboratories's revenue rose $75.8M (+7%) from $1.1B in Q1 2026 to $1.2B in Q2 2026. The biggest changes: Product revenue +$52.5M (+8%); Service revenue +$23.3M (+5%). Gross margin 64.0% against 63.4% (+0.7 pts).
Idexx Laboratories, Q2 2026: revenue $1.2B (+10% year over year), operating margin 35.0%, net earnings $338M, operating cash flow $347M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 64.0% | 63.4% | +0.7 pts |
| Operating margin | 35.0% | 31.8% | +3.2 pts |
| Net margin | 27.8% | 24.4% | +3.4 pts |
| Free cash flow margin | 26.5% | 20.5% | +6.0 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product revenue | $719M | $666M | $52.5M | +8% |
| Service revenue | $498M | $475M | $23.3M | +5% |
| Revenue | $1.2B | $1.1B | $75.8M | +7% |
| Gross profit | $779M | $723M | $56.3M | +8% |
| Cost of revenue | $437M | $418M | $19.4M | +5% |
| Operating profit | $426M | $363M | $63.0M | +17% |
| Operating expenses | $354M | $360M | −$6.6M | -2% |
| Pre-tax earnings | $417M | $355M | $61.8M | +17% |
| Other expense, net | $8.3M | $7.1M | $1.2M | +17% |
| Research & development | $65.4M | $65.8M | −$359K | -0.5% |
| Sales & marketing | $171M | $175M | −$4.0M | -2% |
| General & admin | $117M | $119M | −$2.3M | -2% |
| Net earnings | $338M | $278M | $60.0M | +22% |
| Income tax | $78.8M | $77.0M | $1.8M | +2% |
| Depreciation & amortization | $41.1M | $37.7M | $3.4M | +9% |
| Share-based compensation | $16.1M | $16.3M | −$252K | -2% |
| Working capital & other | $48.4M | $66.2M | −$17.8M | -27% |
| Operating cash flow | $347M | $266M | $80.9M | +30% |
| Free cash flow (OCF − capex) | $323M | $234M | $88.3M | +38% |
| Capital expenditures | $24.6M | $32.0M | −$7.3M | -23% |
Questions
How much did Idexx Laboratories's revenue grow quarter over quarter in Q2 2026?
Idexx Laboratories's revenue rose $75.8M (+7%) from $1.1B in Q1 2026 to $1.2B in Q2 2026.
What drove Idexx Laboratories's revenue change in Q2 2026?
Product revenue +$52.5M (+8%); Service revenue +$23.3M (+5%).